PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease

Area of Science:

• Cardiology
• Interventional Cardiology
• Clinical Trials

Background:

• ST-segment elevation myocardial infarction (STEMI) with multivessel coronary artery disease presents complex treatment challenges.
• Recent randomized controlled trials (RCTs) suggest potential advantages of multivessel percutaneous coronary intervention (PCI) over culprit vessel-only PCI in STEMI patients.
• Updated clinical recommendations highlight the evolving understanding of optimal revascularization strategies.

Purpose of the Study:

• To systematically review and document existing published reports on multivessel PCI versus culprit vessel-only PCI in STEMI patients.
• To critically analyze the limitations of current studies in this field.
• To establish a foundation for future research and clinical decision-making.

Main Methods:

• Comprehensive literature search of randomized controlled trials and relevant clinical studies.
• Critical appraisal of study methodologies, patient populations, and outcome measures.
• Synthesis of evidence regarding the comparative effectiveness of different PCI strategies.

Main Results:

• Evidence from recent RCTs indicates a potential benefit of multivessel PCI in specific STEMI patient subgroups.
• Limitations include heterogeneity in study designs, outcome reporting, and patient selection criteria.
• Current data necessitates further investigation to refine treatment guidelines.

Conclusions:

• Multivessel PCI may be superior to culprit vessel-only PCI in select STEMI patients with multivessel coronary artery disease.
• Further high-quality research is required to definitively establish the optimal revascularization strategy.
• This review underscores the need for personalized treatment approaches based on comprehensive patient assessment.